Original Articles

Effect of Anti Phospholipid Antibodies on in vitro fertilization/intracytoplsmic sperm injection outcome

Abstract

Objective: The study aimed to determine the relationship between presence of antiphospholipid antibodies (APLs) and clinical pregnancy rate in patients undergoing IVF/ICSI procedures.
Materials and methods: This descriptive-analytic study performed on two hundred consecutive women referred for IVF/ICSI in Vali-e-Asr Reproductive Health Research Center. Serum levels of APLs , anticardiolipin [aCL], antiphosphatidic acid [aPA], antiphosphatidyl choline [aPC] and antiphosphatidylserine [aPS] were checked for all patients before starting IVF cycles. APLs  seropositivity and clinical pregnancy rate were determined. T-test and Mann-Whitney were used to compare two groups. P value <0.05 was considered significant.
Results: 23 women (11.5%) were APL positive. Twenty nine women of 177 APL seronegative patients (16.4%) became pregnant while only one of 23 seropositive patients (4.3%) was pregnant. Clinical pregnancy rate was not significantly different in two groups.
Conclusion: Although APLs were common, these antibodies did not affect the outcome of IVF/ICSI procedures. Thus screening for APLs is not recommended in women undergoing these procedures.

-Stern C , Chamley L , Norris H, Hale L , Gordon Baker HW.A randomized , double –blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertility and Sterility 2003; 80 (2): 376-383.

-Mwanda OW. Lupus anticoagulants: pathophysiology, clinical and laboratory associations: a review. East Afr Med J 2003; 80(11): 564-568.

-Harris EN. Clinical and serological features of the antiphospholipid syndrom (APS). Br J Rheumatol 1987; 26: 19.

-Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone.Am J Obstet Gynecol 1996; 174: 1584-1589.

-Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314: 253-257.

-Balasch J, Creus M, Fabregues F, Font J, Martorell J, Vanrell JA. Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer. Fertil Steril 1996; 65: 655-658.

-Birkenfeld A, Mukaida T, Minichiello L, Jackson M, Kase NG, Yemini M. Incidence of autoimmune antibodies in failed embryo transfer cycles. Am J Reprod Immunol 1994; 31: 65-68.

-Coulam CB, Krysa LW, Bustillo M. Intravenous immunoglobulin for in-vitro fertilization failure. Hum Reprod 1994; 9: 2265-2269.

-Balasch J, Creus M, Fabregues F, Reverter JC, Carmona F, Tassies D, et al. Antiphospholipid antibodies and human reproductive failure. Hum Reprod 1996; 11: 2310-2315.

-Coulam CB, Kaider BD, Kaider AS, Janowicz P, Roussev RG. Antiphospholipid antibodies associated with implantation failure after IVF/ET. J Assist Reprod Genet 1997; 14: 603-608.

-Geva E, Yaron Y, Lessing JB, Yovel I, Vardinon N, Burke M, et al. Circulatin autoimmune antibodies may be responsible for implantation failure in in-vitro fertilization. Fertil Steril 1994; 62: 802-806.

-Bronson R. Immunology and reproductive medicine. Hum Reprod 1995; 10: 755-757.

-Coulam CB. Implantation failure and immunotherapy. Hum Reprod 1995; 10: 1338-1340.

-Fisch B, Rikover Y, Shohat L, Zurgil N, Tadir Y, Ovadia J, et al. The relationship between in vitro fertilization and naturally ocurring antibodies: evidence for increased production of antiphospholipid autoantibodies. Fertil Steril 1991; 56: 718-724.

-Birdsall MA, Lockwood GM, Ledger WL, Johnson PM, Chamley LW. Antiphospholipid antibodies in women having in-vitro fertilization. Hum Reprod 1996; 11: 1185-1189.

-Denis AL, Guido M, Adler RD, Bergh PA, Brenner C, Scott RT. Antiphospholipid antibodies and pregnancy rates and outcome in in-vitro fertilization patients. Fertil Steril 1997; 1084-1090.

-El-Roeiy A, Gleicher N, Fribert J, Confino E, Dudkiewicz A. Correlation between peripheral lood and follicular fluid autoantibodies and impact on in-vitro fertilization. Obstet Gynecol 1987; 70: 163-170.

-Gleicher N, Liu H-C, Dudkiewicz A, Rosenwaks Z, Kaberlein G, Pratt D, et al. Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization success.Am J Obstet Gynecol 1994; 170: 1145-1149.

-Kowalik A, Vichnin M, Liu H-C, Braunch W, Berkeley AS. Midfollicular anticardiolipin and antiphosphatidylserine antibody titers do not correlate with in vitro fertilization outcome. Fertil Steril 1997; 68: 298-304.

-Kutteh WH, Yetman DL, Chantilis SJ, Crain J. Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin. Hum Reprod 1997; 12: 1171-1175.

-Sher G, Feinman M, Zouves C, Kuttner G, Maassarani G, Salem R, et al. High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod 1994; 9: 2278-2283.

-Hornstein MD, Davis OK, Massey JB,Paulson RJ, Collins JA. Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis. Fertil Steril 2000 73(2): 330-333.

-Matsubayashi M, Sugi T, Arai T, Kondo A, Suzuki T , Izumi SI. Different antiphospholipid antibody specificities are found in association with early repeated pregnancy loss versus recurrent in-vitro fertilization failure patients. Am J Reprod Immunol 2001; 46(5): 323.

-Backos M, Rai R, Regan L. Antiphospholipid antibody and infertility. Hum Fertil 2002; 5(1): 30-34.

-Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population .Am J Obstet Gynecol 1989; 161: 369-373.

-Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS. Antiphospholipid antibodies in pregnancy: prevalence and clinical association. Br J Obstet Gynecol 1993; 100: 909-913.

-Udoff LC,Branch DW.Management of pationts with antiphospholipid antibodies undergoing in Vitro fertilization.J Autoimmune 2000; 15(2): 209-211.

-Huong DL, Wechsler B,Piette JC,Arfi S,Gallinari C ,Darbois Y, et al.Risks of ovulation-induction therapy in systemic Lupus erythematosus. Br J Rheumatol 1996; 35(11): 1184-1186.

-Shoenfeld Y,carp HJ, Molina V,blank M, Cervera R, Balasch J, et al.Autoantibodies and Prediction of reproductive failure.Am J Reprod Immunol 2006; 56(5-6): 337-344.

-Egbase PE,Al Shahran M ,Diejomaoh M,Grudzinskas JG.Antiphospholipid antibodies in infertile couple with two consecutive miscarriages after in-vitro fertilization and embryo transfer.Hum Reprod 1999; 14(6): 1483-1486.

-Szymanski W,Zielinska I.Application of IVF in women with endometriosis. Ginecol Pol 2001; 72(5): 273-277.

Files
IssueVol 1, No 1 (September 2007) QRcode
SectionOriginal Articles
Keywords
Anti phospholipid antibodies Intra Cytoplasmic Sperm Injection

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Azimi Nekoo E, Shahrokh Tehrani Nejad E, Rashidi B, Kilani H, Moazami Goudarzi H. Effect of Anti Phospholipid Antibodies on in vitro fertilization/intracytoplsmic sperm injection outcome. J Family Reprod Health. 2007;1(1):36-40.